Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05080725 · ClinicalTrials.gov registry record · NA
Measuring Pharyngeal Muscle Improvements Following Behavioral Swallowing Exercises
A NA study of Dysphagia, sponsored by NYU Langone Health.
- Completed
- Registry status
- NA
- Development phase
- 2
- Enrollment target
- 1
- Study location
NCT05080725: Completed NA study of Dysphagia, sponsored by NYU Langone Health.
NCT05080725 is a NA study of Dysphagia that has completed, run by NYU Langone Health. The registered enrollment target is 2 participants, below the 172-participant average among 35 other Dysphagia trials with a reported enrollment target (99% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05080725, a NA study of Dysphagia, has completed, sponsored by NYU Langone Health.
- COMPLETED
- Registry status
- NA
- Development phase
- 2 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study is to learn more about how exercise and protein supply affect swallow muscles. Twenty healthy older adults will be recruited from local community centers, physician offices, and retirement communities via flyers. Participants will complete 16 sessions of standard of care swallowing exercises 2 times per week for 8 weeks. All sessions will be conducted via Zoom. During each session, a series of swallow exercises will be performed following a demonstration from a trained speech-language pathologist. Participants will be referred to NYU Langone Health or White Plains Hospital, for a videofluoroscopic swallowing study, acoustic pharyngometry and measures of hand grip strength before and after the treatment protocol. Patients will be able to select their preferred site for swallow study completion. Results will inform the relationship between swallow exercises and pharyngeal muscles. All devices and exercises are established as safe and effective and are FDA approved.
Primary Outcome
2D lateral videofluoroscopic images will be used to measure pharyngeal constriction pre and post intervention
Conditions Studied
Interventions
- OTHER TelePEPP intervention
Study Locations (1)
New York
- NYU Langone Health - New York
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 2 participants |
| Start Date | 2022-05-24 |
| Est. Completion | 2022-10-04 |
| Phase | NA |
What the finished NCT05080725 record still lists
NCT05080725 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 2 participants, a relatively small participant target, below the 172-participant average among 35 other Dysphagia trials with a reported enrollment target (99% lower).
The record links to 1 condition, with Dysphagia appearing as the primary indexed condition, and to 1 intervention - of which TelePEPP intervention is the first listed.
NCT05080725 reports a single indexed study location in New York.
Frequently Asked Questions
What is clinical trial NCT05080725 about?
NCT05080725 is a clinical study titled "Measuring Pharyngeal Muscle Improvements Following Behavioral Swallowing Exercises". The purpose of this study is to learn more about how exercise and protein supply affect swallow muscles. Twenty healthy older adults will be recruited from local community centers, physician offices, and retirement communities via flyers. Participants will complete 16 sessions of standard of care sw...
What is the current status of trial NCT05080725?
This trial is currently completed. It is a NA study. The enrollment target is 2 participants. The study started on 2022-05-24. Estimated completion is 2022-10-04.
What conditions does trial NCT05080725 study?
This clinical trial studies the following conditions: Dysphagia.
What interventions are being tested in trial NCT05080725?
The interventions under investigation include: TelePEPP intervention (OTHER).
Who is sponsoring clinical trial NCT05080725?
This trial is sponsored by NYU Langone Health, which has 1,164 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05080725 being conducted?
This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Dysphagia
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT05080725's enrollment target sits among peer trials
2 36th of 35 the lowest of 35 other Dysphagia trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Dysphagia trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Dissemination and Implementation of DIGEST™ as an Evidence-based Measurement Tool for Dysphagia: A Randomized Implementation Trial
RECRUITING · NA
-
Effect of Thickened Feeds on Swallow Physiology in Children With Dysphagia
RECRUITING · NA
-
Velopharyngeal Dysfunction in Head & Neck Cancer Patients, Pilot Study
RECRUITING · NA
-
Evolution of the Chicago Classification: Bridging Physiology and Mechanics
RECRUITING · NA
-
External Pharyngeal Exerciser and Pharyngeal Phase of Swallowing
RECRUITING · NA
-
The Esophageal String Test as a Diagnostic Screening Tool for Eosinophilic Esophagitis Among Africans With Dysphagia in Mali and the United States
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI